Acteurs : Acteur Ulrich STEIN

0
home-3402961
Nom
Ulrich STEIN
Coordonnées
Ulrich SteinCentre Hospitalier Universitaire de BesançonService Oncologie Médicale Hôpital Jean Minjoz2, bd Fleming

25030 Besancon

Affiliation(s)
Equipe de recherche
Equipe FC32 – Xavier PIVOT •
Aires d’expertise
Clinique:Oncologie Médicale
Axes du CGE
5 : Compréhension et maîtrise des échecs thérapeutiques
Collègues
Equipe FC32

  • Christophe BORG
  • Loïc CHAIGNEAU
  • Martin DEMARCHI
  • Emmanuel GUARDIOLA
  • Tristan MAURINA
  • N.U. NGUYEN
  • Xavier PIVOT
  • Christian VILLANUEVA
Projets
Equipe FC32

2004 – RESPONSESHIFT (porteur : Franck Bonnetain)
Qualité de vie, « response shift » et attentes de santé : analyse longitudinale chez les patientes ayant un cancer du sein
Projets hors INCa
Equipe FC32

  • 2005 – PHRC – Adrecis 2
  • 2005 – PHRC – Immunothérapie NK
Publications


Guardiola E, Delroeux D, Heyd B, Combe M, Lorgis V, Demarchi M, Stein U, Royer B, Chauffert B, Pivot X. Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer. World J Surg Oncol. 2009 Feb 9;7:14.

Viel E, Demarchi MF, Chaigneau L, Nguyen T, Legat C, Stein U, Thiery-Vuillemin A, Limat S, Pivot X, Borg C. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies. Am J Clin Oncol. 2008 Feb;31(1):89-94.

Pivot X, Villanueva C, Chaigneau L, Nguyen T, Demarchi M, Maurina T, Stein U, Borg C. Ixabepilone, a novel epothilone analog in the treatment of breast cancer. Expert Opin Investig Drugs. 2008 Apr;17(4):593-9. Review

Thiery-Vuillemin A, Chaigneau L, Meaux-Ruault N, Villanueva C, N’guyen T, Maurina T, Stein U, Lorgis V, Demarchi M, Pivot X. Anticancer therapy in patients with porphyrias: evidence today. Expert Opin Drug Saf. 2008 Mar;7(2):159-65.

Limat S, Bracco-Nolin CH, Legat-Fagnoni C, Chaigneau L, Stein U, Huchet B, Pivot X, Woronoff-Lemsi MC. Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer. Eur J Health Econ. 2006 Jun;7(2):107-13.

Conroy T, Paillot B, Francois E, Bugat R, Jacob JH, Stein U, Nasca S, Metges JP, Rixe O, Michel P, Magherini E, Hua A, Deplanque G. Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer–a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study. J Clin Oncol. 2005 Feb 20;23(6):1228-36.
home-3402961pixel-3137601uguest-2335456 poweredby-4412466